SLC13A5 CITRATE TRANSPORTER DISORDER

Clinical trials for SLC13A5 CITRATE TRANSPORTER DISORDER explained in plain language.

Never miss a new study

Get alerted when new SLC13A5 CITRATE TRANSPORTER DISORDER trials appear

Sign up with your email to follow new studies for SLC13A5 CITRATE TRANSPORTER DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Gene therapy hope for kids with rare citrate disorder

Disease control Recruiting now

This early-stage trial tests a single dose of TSHA-105, a gene therapy injected into the spinal fluid, in 8 people aged 2 to 20 with SLC13A5 citrate transporter disorder. The goal is to see if it is safe and whether it can improve motor and thinking skills. Because the trial is v…

Matched conditions: SLC13A5 CITRATE TRANSPORTER DISORDER

Phase: PHASE1, PHASE2 • Sponsor: TESS Research Foundation • Aim: Disease control

Last updated Jul 02, 2026 00:00 UTC

SLC13A5 CITRATE TRANSPORTER DISORDER

Get alerted when new SLC13A5 CITRATE TRANSPORTER DISORDER trials appear

Gene therapy hope for kids with rare citrate disorder